Patrick Hwu: Our annual Board Retreat at Moffitt Cancer Center
“Last week, we hosted our annual Board Retreat at Moffitt Cancer Center.
The retreat started Thursday evening with a reception at our Speros FL campus under development in Pasco County, Florida. Board members had an opportunity to tour the construction sites for our Moffitt Ambulatory Clinic, Proton Therapy Center and Research Innovation Center, and hear from respective leaders about each.
On Friday, board members joined us for a full-day retreat, which included board annual meetings, a strategic update, a panel discussion on clinical trials and the unveiling of our new Ferman Family Mobile Lung Screening Unit!
We ended the day with a fireside chat featuring Senator Connie Mack, James Mule‘ and our Institute Board Chair, Tim Adams. The inspiring discussion explored the history of TIL Therapy at Moffitt, from the vision and the science to the philanthropy that accelerated and bolstered our efforts.
Collaboration and alignment with Moffitt board members is critical to our strategic vision and drives meaningful impact for our patients and the greater community.
Thank you to all of our board members for joining us and for your continued dedication to advancing the prevention and cure of cancer!”
More posts featuring Patrick Hwu.
Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy.
He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.
Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research.
Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023